Osaka, Japan

Tomohiro Nakayama

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Sumitomo Chemical Company, Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiro Nakayama. Retrieved from https://idiyas.com/inventor/tomohiro-nakayama-mpl1bib0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomohiro Nakayama: Innovator in Chemical Compounds

Introduction

Tomohiro Nakayama is a prominent inventor based in Osaka, Japan. He is known for his contributions to the field of chemical compounds. With a focus on innovation, Nakayama has made significant strides in his career.

Latest Patents

Tomohiro Nakayama holds a patent for a compound, showcasing his expertise in chemical innovation. His work has led to advancements that are beneficial in various applications.

Career Highlights

Nakayama is currently employed at Sumitomo Chemical Company, Limited, where he continues to develop and refine his inventions. His dedication to research and development has positioned him as a key player in the industry.

Collaborations

He collaborates with Takuma Aoki, another talented individual in the field. Together, they work on projects that push the boundaries of chemical research.

Conclusion

Tomohiro Nakayama's contributions to the field of chemical compounds highlight his innovative spirit and commitment to advancing technology. His work at Sumitomo Chemical Company, Limited, and his collaboration with Takuma Aoki further emphasize his role as a leading inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…